Bill Facteau - 18 Oct 2023 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
18 Oct 2023
Net transactions value
$0
Form type
4
Filing time
19 Oct 2023, 17:01:18 UTC
Next filing
16 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Stock Option (right to buy) Award $0 +31,085 $0.000000 31,085 18 Oct 2023 Common Stock 31,085 $0.4029 Direct F1
transaction BCDA Stock Option (right to buy) Award $0 +12,434 $0.000000 12,434 18 Oct 2023 Common Stock 12,434 $0.4029 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.